Company: OFIX
Filing Date: 2025-02-25
Form Type: 10-K
Source: 0000950170-25-026066
Chunk: 219

Company: Orthofix Medical Inc.
Filing Date: 2025-02-25
Form: 10-K
Item: Item 1B
Chunk 219
---
4,650

    —

    Cash, cash equivalents, and restricted cash at the end of the year
     
    $
    85,738

    $
    37,757

    $
    50,700

The accompanying notes form an integral part of these consolidated financial statements

F-7

ORTHOFIX MEDICAL INC. 

Notes to the Consolidated Financial Statements

1.	Business and basis of presentation Description of the BusinessOrthofix Medical Inc. (the "Company" or "Orthofix") is a global medical technology company headquartered in Lewisville, Texas. By providing medical technologies that heal musculoskeletal pathologies, the Company delivers exceptional experiences and life-changing solutions to patients around the world. Orthofix offers a comprehensive portfolio of spinal hardware, bone growth therapies, specialized orthopedic solutions, biologics, and enabling technologies, including the 7D FLASH navigation system.Basis of PresentationThe consolidated financial statements include the financial statements of the Company and its wholly owned subsidiaries. All intercompany accounts and transactions are eliminated in consolidation. Information on our accounting policies and methods used in the preparation of our consolidated financial statements are included, where applicable, in the respective footnotes that follow.

      Footnote
       
      Footnote Reference

      Business and basis of presentation
       
      1

      Significant accounting policies
       
      2

      Recently adopted accounting standards and recently issued accounting pronouncements
       
      3

      Mergers and acquisitions
       
      4

      Inventories
       
      5

      Property, plant, and equipment
       
      6

      Intangible assets
       
      7

      Goodwill
       
      8

      Leases
       
      9

      Other current liabilities
       
      10

      Indebtedness
       
      11

      Fair value measurements and investments
       
      12

      Commitments and contingencies
       
      13

      Shareholders' equity
       
      14

      Revenue recognition and accounts receivable
       
      15

      Business segment information
       
      16

      Acquisition-related amortization and remeasurement
       
      17

      Share-based compensation
       
      18

      Defined contribution plans and deferred compensation
       
      19

      Income taxes
       
      20

      Earnings per share